The Indian government plans to set up Rs 500 crore venture capital fund to boost domestic pharma industry and provide cheaper loans to...

New cell-culture techniques, biomanufacturing formats, biological products, and the expansion of single-use applications are driving...

Tony Coles could have had any job he wanted in the drug industry. In five years at the helm of cancer drug developer Onyx Pharmaceuticals...

The FDA announced the availability of a draft guidance describing its proposal on the nonproprietary naming of biological products....

Small-molecule treatments are invaluable in providing symptomatic benefits for an array of illnesses. However, many serious conditions —...

About two-thirds of drug launches don’t meet expectations. Improving that record requires pharmaceutical companies to recognize the world...

From www.peoplespharmacy.com Why don’t patients and their doctors trust generic drugs? Despite the fact that 84 percent of all...

From www.consumermedsafety.org Coming up with a name for a new medicine isn’t as easy as you think. Drug companies look for names that...

Healthcare payers are gearing up for huge savings from a slew of new biosimilars due to hit the market, but regulators are debating how...

MUMBAI: Pharma companies can breathe a tad easier. It is learnt that the government has dropped plans to enforce a ban on use of brand...

2015 was a good year for innovation in medicine with the U.S. Food and Drug Administration approving 45 novel drugs, four more than in...

Several Americans who say they’ve been dangerously harmed by generic drugs — and were unaware of the risk because the drug maker did not...

Biopharmaceutical companies focused on patient outcomes are enjoying more commercial success and outperforming their peers. Our research...

Capecitabine (C15H22FN3O6) is an oncologically important chemotherapeutic prodrug. It has a trade name: Xeloda (pronounced zee-ló-da, I...

ALLSCHWIL, SWITZERLAND - 26 June 2015 - Actelion Ltd (SIX: ATLN) today announced the creation of a start-up, together with the Max Planck...

Utrecht University (The Netherlands) and the World Health Organisation (WHO) will work together to make affordable patent-free medicines...

From www.dddmag.com – February 18, 2015 Actavis will change the company name after the completed acquisition of Allergan. Actavis, the...

The Dutch Consulate and Globrands' pharmanaming.com cordially invite you to an informative and eye opening seminar, on how to make your...